Nicole Lambert - 03 Aug 2021 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role: Director
Signature: /s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol: RCUS
Transactions as of: 03 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 05 Aug 2021, 16:28:18 UTC
Previous filing: 01 Nov 2021
Next filing: 26 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCUS	Common Stock	Award	$0	+4,700		$0.000000	4,700	03 Aug 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCUS	Stock Option (Right to Buy)	Award	$0	+21,700		$0.000000	21,700	03 Aug 2021	Common Stock	21,700	$30.02	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units that vest in three equal annual installments on each of September 15, 2022, September 15, 2023, and September 15, 2024, subject to the Reporting Person's continued service to the Company.
F2	The option is exercisable in 36 equal monthly installments after August 3, 2021, subject to the Reporting Person's continued service to the Company.